K S Reynolds

Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review

Ping Zhao, L Zhang, Joseph A. Grillo et al. · Clinical Pharmacology & Therapeutics · 2010 · 518 citations

Pharmacy, Pharmacokinetics, Pharmacology +13

Therapeutic Protein–Drug Interactions and Implications for Drug Development

Huang Sm, Hong Zhao, Ji Lee et al. · Clinical Pharmacology & Therapeutics · 2010 · 139 citations

Veterinary Medicine, Pharmacokinetics, Pharmacology +17

Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug

Md L T Vieira, Brian J. Kirby, Isabelle Ragueneau‐Majlessi et al. · Clinical Pharmacology & Therapeutics · 2013 · 101 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Predicting Drug Interaction Potential With a Physiologically Based Pharmacokinetic Model: A Case Study of Telithromycin, a Time-Dependent CYP3A Inhibitor

Md L T Vieira, Ping Zhao, Eva Gil Berglund et al. · Clinical Pharmacology & Therapeutics · 2012 · 41 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Acute fluoride toxicity: The influence of acid-base status

K S Reynolds · Toxicology and Applied Pharmacology · 1978 · 36 citations

Pharmacy, Toxicology, Environmental Toxicology +12